-
1
-
-
71049195158
-
Prosthetic heart valves
-
internet site
-
Kardon E. Prosthetic heart valves. 2007. eMedicine internet site. www.emedicine.com/emerg/topic797.htm.
-
(2007)
eMedicine
-
-
Kardon, E.1
-
2
-
-
0037164257
-
ABC of antithrombotic therapy. Valvuar heart disease and prosthetic heart valves
-
Goldsmith I, Turpie AGG, Lip GYH. ABC of antithrombotic therapy. Valvuar heart disease and prosthetic heart valves. Br Med J 2002; 325: 1228-231.
-
(2002)
Br Med J
, vol.325
, pp. 1228-1231
-
-
Goldsmith, I.1
Turpie, A.G.G.2
Lip, G.Y.H.3
-
3
-
-
4644371108
-
-
Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horskotte D, Miller N et al. Antithrombotic therapy in valvular heart disease - native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 457-82.
-
Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horskotte D, Miller N et al. Antithrombotic therapy in valvular heart disease - native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 457-82.
-
-
-
-
4
-
-
0028934029
-
Long-term results of valve replacement with the St. Jude Medical prosthesis
-
Baudet EM, Puel V, McBride JT, Grimaud JP, Roques F, Clerc F et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995; 109: 858-70.
-
(1995)
J Thorac Cardiovasc Surg
, vol.109
, pp. 858-870
-
-
Baudet, E.M.1
Puel, V.2
McBride, J.T.3
Grimaud, J.P.4
Roques, F.5
Clerc, F.6
-
5
-
-
84907134754
-
Management of thrombo-embolism after aortic valve replacement with the Bjork-Shiley tilting disc valve: Medicamental prevention with dicumarol in comparison with dipyrimidamole-acetylsalicylic acid; surgical treatment of prosthetic thrombosis
-
Bjork VO, Henze A. Management of thrombo-embolism after aortic valve replacement with the Bjork-Shiley tilting disc valve: medicamental prevention with dicumarol in comparison with dipyrimidamole-acetylsalicylic acid; surgical treatment of prosthetic thrombosis. Scand J Thorac Cardiovasc Surg 1975; 9: 183-91.
-
(1975)
Scand J Thorac Cardiovasc Surg
, vol.9
, pp. 183-191
-
-
Bjork, V.O.1
Henze, A.2
-
6
-
-
0029121472
-
Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart valve replacement: A meta analysis
-
Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart valve replacement: a meta analysis. Am Heart J 1995; 130: 547-52.
-
(1995)
Am Heart J
, vol.130
, pp. 547-552
-
-
Cappelleri, J.C.1
Fiore, L.D.2
Brophy, M.T.3
Deykin, D.4
Lau, J.5
-
7
-
-
0026647984
-
Pregnancy in patients with prosthetic heart valves: The effect of anticoagulation on mother, fetus and neonate
-
Born D, Martinez EE, Almeida PAM, Santos DV, Carvalho ACC, Moron AF. Pregnancy in patients with prosthetic heart valves: the effect of anticoagulation on mother, fetus and neonate. Am Heart J 1992; 124: 413-17.
-
(1992)
Am Heart J
, vol.124
, pp. 413-417
-
-
Born, D.1
Martinez, E.E.2
Almeida, P.A.M.3
Santos, D.V.4
Carvalho, A.C.C.5
Moron, A.F.6
-
8
-
-
0028209979
-
Outcome of pregnancy in women with valve prostheses
-
Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994; 71: 196-201.
-
(1994)
Br Heart J
, vol.71
, pp. 196-201
-
-
Sbarouni, E.1
Oakley, C.M.2
-
9
-
-
0028329975
-
Grossesses chez les porteuses de prostheses valvulaires: Etude cooperative retrospective francaise (155 cas). [Pregnancy in patients with heart valve prosthesis. A French retrospective cooperative study (155 cases)]
-
Hanania G, Thomas D, Michel PL, Garbarz E, Age C, Millair A et al. Grossesses chez les porteuses de prostheses valvulaires: etude cooperative retrospective francaise (155 cas). [Pregnancy in patients with heart valve prosthesis. A French retrospective cooperative study (155 cases)] Arch Mal Coeur Vaiss 1994; 87: 429-37.
-
(1994)
Arch Mal Coeur Vaiss
, vol.87
, pp. 429-437
-
-
Hanania, G.1
Thomas, D.2
Michel, P.L.3
Garbarz, E.4
Age, C.5
Millair, A.6
-
10
-
-
0028047676
-
Pregnancy following cardiac prosthetic valve replacement
-
Lee CN, Wu CC, Lin PY, Hsieh FJ, Chen HY. Pregnancy following cardiac prosthetic valve replacement. Obstet Gynecol 1994; 83: 353-56.
-
(1994)
Obstet Gynecol
, vol.83
, pp. 353-356
-
-
Lee, C.N.1
Wu, C.C.2
Lin, P.Y.3
Hsieh, F.J.4
Chen, H.Y.5
-
11
-
-
0020665703
-
Pregnancy in patients after homograft cardiac valve replacement
-
Denbow CE, Matadial L, Sivapragasam S, Spencer H. Pregnancy in patients after homograft cardiac valve replacement. Chest 1983; 83: 540-42.
-
(1983)
Chest
, vol.83
, pp. 540-542
-
-
Denbow, C.E.1
Matadial, L.2
Sivapragasam, S.3
Spencer, H.4
-
12
-
-
0030847542
-
Pregnancy in patients with pulmonary autograft valve replacement
-
Dore A, Somerville J. Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 1997; 18: 1659-62.
-
(1997)
Eur Heart J
, vol.18
, pp. 1659-1662
-
-
Dore, A.1
Somerville, J.2
-
13
-
-
0032711910
-
Pregnancy through a prosthetic heart valve
-
Elkayam U. Editorial comment
-
Elkayam U. Editorial comment. Pregnancy through a prosthetic heart valve. J Am Coll Card 1999; 33: 1642-45.
-
(1999)
J Am Coll Card
, vol.33
, pp. 1642-1645
-
-
-
14
-
-
20044381342
-
Prevention and treatment of venous thromboembolism in high risk situations in pregnancy
-
McLeod AG, Ellis C. Prevention and treatment of venous thromboembolism in high risk situations in pregnancy. Fet Mat Med Rev 2005; 16: 151-70.
-
(2005)
Fet Mat Med Rev
, vol.16
, pp. 151-170
-
-
McLeod, A.G.1
Ellis, C.2
-
15
-
-
0026561877
-
Venous thrombosis during pregnancy: Leg and trimester of presentation
-
Ginsberg JS, Brill-Edwards P, Burrows RF, Bona R, Prandoni P, Buller HR et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 1992; 67: 519-20.
-
(1992)
Thromb Haemost
, vol.67
, pp. 519-520
-
-
Ginsberg, J.S.1
Brill-Edwards, P.2
Burrows, R.F.3
Bona, R.4
Prandoni, P.5
Buller, H.R.6
-
16
-
-
0033231697
-
Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy
-
Gherman RB, Goodwin TM, Leung B, Byrne JD, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 730-34.
-
(1999)
Obstet Gynecol
, vol.94
, pp. 730-734
-
-
Gherman, R.B.1
Goodwin, T.M.2
Leung, B.3
Byrne, J.D.4
Hethumumi, R.5
Montoro, M.6
-
17
-
-
0032908014
-
Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation
-
Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999; 54: 265-71.
-
(1999)
Obstet Gynecol Surv
, vol.54
, pp. 265-271
-
-
Ray, J.G.1
Chan, W.S.2
-
18
-
-
0024546774
-
Risks to the fetus of anticoagulant therapy during pregnancy
-
Ginsberg JS, Hirsh J, Turner DC, Levine MN, Burrows R. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989; 61: 197-203.
-
(1989)
Thromb Haemost
, vol.61
, pp. 197-203
-
-
Ginsberg, J.S.1
Hirsh, J.2
Turner, D.C.3
Levine, M.N.4
Burrows, R.5
-
19
-
-
0018916729
-
Maternal and fetal sequelae of anticoagulation during pregnancy
-
Hall JAG, Paul RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122-140.
-
(1980)
Am J Med
, vol.68
, pp. 122-140
-
-
Hall, J.A.G.1
Paul, R.M.2
Wilson, K.M.3
-
20
-
-
0038600299
-
Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature
-
Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Int Med 2000; 160: 191-96.
-
(2000)
Arch Int Med
, vol.160
, pp. 191-196
-
-
Chan, W.S.1
Anand, S.2
Ginsberg, J.S.3
-
21
-
-
0032934132
-
Anticoagualation therapy in pregnancy
-
Robin F, Lecuru F, Desfeux P, Boucaya B, Taurelle R. Anticoagualation therapy in pregnancy. Eur J Obstet Gynecol Reprod Biol 1999; 83: 171-77.
-
(1999)
Eur J Obstet Gynecol Reprod Biol
, vol.83
, pp. 171-177
-
-
Robin, F.1
Lecuru, F.2
Desfeux, P.3
Boucaya, B.4
Taurelle, R.5
-
22
-
-
0017600978
-
Multiple congenital anomalies associated with oral anticoagulants
-
Shaul WL, Hall JG. Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol 1997; 127: 191-95.
-
(1997)
Am J Obstet Gynecol
, vol.127
, pp. 191-195
-
-
Shaul, W.L.1
Hall, J.G.2
-
23
-
-
0024462373
-
Heparin therapy during pregnancy: Risk to the fetus and mother
-
Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R. Heparin therapy during pregnancy: risk to the fetus and mother. Arch Int Med 1989; 149: 2233-36.
-
(1989)
Arch Int Med
, vol.149
, pp. 2233-2236
-
-
Ginsberg, J.S.1
Kowalchuk, G.2
Hirsh, J.3
Brill-Edwards, P.4
Burrows, R.5
-
24
-
-
0035988266
-
Low-molecular-weight heparin for the treatment of patients with mechanical heart valves
-
Shapira Y, Sagie A, Battler A. Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol 2002; 25: 323-27.
-
(2002)
Clin Cardiol
, vol.25
, pp. 323-327
-
-
Shapira, Y.1
Sagie, A.2
Battler, A.3
-
25
-
-
1842741383
-
Bridging therapy with low molecular weight heparin in pregnant patients and patients with mechanical prosthetic heart valves
-
Groce JB. "Bridging" therapy with low molecular weight heparin in pregnant patients and patients with mechanical prosthetic heart valves. J Thromb Thrombolysis 2003; 16: 79-82.
-
(2003)
J Thromb Thrombolysis
, vol.16
, pp. 79-82
-
-
Groce, J.B.1
-
26
-
-
0035125030
-
Antithrombotic therapy in patients with mechanical and bioprosthetic heart valves
-
Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG. Antithrombotic therapy in patients with mechanical and bioprosthetic heart valves. Chest 2001; 119: 220-27.
-
(2001)
Chest
, vol.119
, pp. 220-227
-
-
Stein, P.D.1
Alpert, J.S.2
Bussey, H.I.3
Dalen, J.E.4
Turpie, A.G.G.5
-
27
-
-
0034646290
-
Low molecular weight heparin after mechanical heart valve replacement
-
Montalescot G, Polle V, Collet JP, Leprince P, Bellanger A, Gandjbakhch I. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000; 1010: 1083-1086.
-
(2000)
Circulation
, vol.1010
, pp. 1083-1086
-
-
Montalescot, G.1
Polle, V.2
Collet, J.P.3
Leprince, P.4
Bellanger, A.5
Gandjbakhch, I.6
-
28
-
-
39549111211
-
Pregnancy, mechanical heart valves and anticoagulation: Navigating the complexities of management during gestation
-
Rosene-Montella K, Keely EJ, Lee RV, Barbour LA eds, 2nd Edition. Philadelphia, American College of Physicians
-
Maxwell CV, Poppas A, Dunn E, Sermer M. Pregnancy, mechanical heart valves and anticoagulation: Navigating the complexities of management during gestation. In: Rosene-Montella K, Keely EJ, Lee RV, Barbour LA (eds) From Medical Care of the Pregnant Patient, 2nd Edition. Philadelphia, American College of Physicians, 2007; 344-355.
-
(2007)
From Medical Care of the Pregnant Patient
, pp. 344-355
-
-
Maxwell, C.V.1
Poppas, A.2
Dunn, E.3
Sermer, M.4
-
30
-
-
0035160309
-
Venous thromboembolism during pregnancy: A retrospective study of enoxaparin safety in 624 pregnancies
-
Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG 2001; 108: 1134-140.
-
(2001)
BJOG
, vol.108
, pp. 1134-1140
-
-
Lepercq, J.1
Conard, J.2
Borel-Derlon, A.3
Darmon, J.Y.4
Boudignat, O.5
Francoual, C.6
-
31
-
-
0021236578
-
Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound
-
Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557-60.
-
(1984)
Thromb Res
, vol.34
, pp. 557-560
-
-
Forestier, F.1
Daffos, F.2
Capella-Pavlovsky, M.3
-
32
-
-
0032932342
-
Safety of low molecular weight heparin in pregnancy; a systematic review
-
Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E et al. Safety of low molecular weight heparin in pregnancy; a systematic review. Thromb Haemost 1999; 81: 669-72.
-
(1999)
Thromb Haemost
, vol.81
, pp. 669-672
-
-
Sanson, B.J.1
Lensing, A.W.2
Prins, M.H.3
Ginsberg, J.S.4
Barkagan, Z.S.5
Lavenne-Pardonge, E.6
-
33
-
-
0031055634
-
Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies
-
Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997; 77: 39-43.
-
(1997)
Thromb Haemost
, vol.77
, pp. 39-43
-
-
Hunt, B.J.1
Doughty, H.A.2
Majumdar, G.3
Copplestone, A.4
Kerslake, S.5
Buchanan, N.6
-
34
-
-
0030957087
-
Low molecular weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
-
Nelson-Piercy C, Letsky EA, de Swiet M. Low molecular weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176: 1062-1068.
-
(1997)
Am J Obstet Gynecol
, vol.176
, pp. 1062-1068
-
-
Nelson-Piercy, C.1
Letsky, E.A.2
de Swiet, M.3
-
35
-
-
0029035681
-
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
-
Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. NEJM 1995; 332:1330-336.
-
(1995)
NEJM
, vol.332
, pp. 1330-1336
-
-
Warkentin, T.E.1
Levine, M.N.2
Hirsh, J.3
Horsewood, P.4
Roberts, R.S.5
Gent, M.6
-
36
-
-
0029034399
-
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: A randomized controlled trial
-
de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ et al. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial. Ann Intern Med 1995; 123: 1-9.
-
(1995)
Ann Intern Med
, vol.123
, pp. 1-9
-
-
de Valk, H.W.1
Banga, J.D.2
Wester, J.W.3
Brouwer, C.B.4
van Hessen, M.W.5
Meuwissen, O.J.6
-
37
-
-
0027442550
-
Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172)
-
Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993; 70: 554-61.
-
(1993)
Thromb Haemost
, vol.70
, pp. 554-561
-
-
Magnani, H.N.1
-
38
-
-
0029880831
-
The effects of long-term heparin therapy during pregnancy on bone density
-
Douketis JD, Ginsberg JS, Burrows RF, Duku EK, Webber CE, Brill-Edwards P. The effects of long-term heparin therapy during pregnancy on bone density. Thromb Haemost 1996; 75: 254-57.
-
(1996)
Thromb Haemost
, vol.75
, pp. 254-257
-
-
Douketis, J.D.1
Ginsberg, J.S.2
Burrows, R.F.3
Duku, E.K.4
Webber, C.E.5
Brill-Edwards, P.6
-
39
-
-
0027467168
-
Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
-
Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265-270.
-
(1993)
Am J Obstet Gynecol
, vol.168
, pp. 1265-1270
-
-
Dahlman, T.C.1
-
40
-
-
0028121058
-
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications for coumarin
-
Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications for coumarin. Thromb Haemost 1994; 71: 7-11.
-
(1994)
Thromb Haemost
, vol.71
, pp. 7-11
-
-
Monreal, M.1
Lafoz, E.2
Olive, A.3
del Rio, L.4
Vedia, C.5
-
41
-
-
0036166519
-
Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin
-
Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002; 87: 182-86.
-
(2002)
Thromb Haemost
, vol.87
, pp. 182-186
-
-
Pettila, V.1
Leinonen, P.2
Markkola, A.3
Hiilesmaa, V.4
Kaaja, R.5
-
42
-
-
0023747897
-
Pharmacokinetics of low molecular weight heparins
-
Bara L, Samama MM. Pharmacokinetics of low molecular weight heparins. Acta Chir Scand 1988; 543: 65-72.
-
(1988)
Acta Chir Scand
, vol.543
, pp. 65-72
-
-
Bara, L.1
Samama, M.M.2
-
43
-
-
0023245673
-
ORG 10172: A low molecular weight heparinoid anticoagulant with a long half life in man
-
Bradbrook ID, Magnani HN, Moelker HC, Morrison PJ, Robinson J, Rogers HJ et al. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half life in man. Br J Clin Pharmacol 1987; 23: 667-75.
-
(1987)
Br J Clin Pharmacol
, vol.23
, pp. 667-675
-
-
Bradbrook, I.D.1
Magnani, H.N.2
Moelker, H.C.3
Morrison, P.J.4
Robinson, J.5
Rogers, H.J.6
-
44
-
-
0030858230
-
Low-molecular-weight heparins
-
Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-98.
-
(1997)
N Engl J Med
, vol.337
, pp. 688-698
-
-
Weitz, J.I.1
-
45
-
-
0019163952
-
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin
-
Jordan RE, Oosta GM, Gardner WT, Rosenberg RD. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. J Biol Chem 1980; 255: 10081-10090.
-
(1980)
J Biol Chem
, vol.255
, pp. 10081-10090
-
-
Jordan, R.E.1
Oosta, G.M.2
Gardner, W.T.3
Rosenberg, R.D.4
-
46
-
-
0019499060
-
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin
-
Holmer E, Kurachi K, Soderstrom G. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J 1981; 193: 395-400.
-
(1981)
Biochem J
, vol.193
, pp. 395-400
-
-
Holmer, E.1
Kurachi, K.2
Soderstrom, G.3
-
47
-
-
0022494017
-
Heparin and its low molecular weight derivatives: Anticoagulant and antithrombotic properties
-
Holmer E, Soderberg K, Bergqvist D, Lindahl U. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties. Haemostasis 1986; 16: 1-7.
-
(1986)
Haemostasis
, vol.16
, pp. 1-7
-
-
Holmer, E.1
Soderberg, K.2
Bergqvist, D.3
Lindahl, U.4
-
48
-
-
0022005992
-
Comparative pharmacokinetics of low molecular weight heparin and unfractionated heparin after intravenous and subcutaneous administration
-
Bara L, Billaud E, Gramond G, Kher A, Samama M. Comparative pharmacokinetics of low molecular weight heparin and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res 1985; 39: 631-36.
-
(1985)
Thromb Res
, vol.39
, pp. 631-636
-
-
Bara, L.1
Billaud, E.2
Gramond, G.3
Kher, A.4
Samama, M.5
-
49
-
-
0028236050
-
Adjusted versus fixed doses of the low-molecular-weight heparin Fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group
-
Alhenc-Gelas M, Jestin-Le Guernic C, Vitoux JF, Kher A, Aiach M, Fiessinger JN. Adjusted versus fixed doses of the low-molecular-weight heparin Fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group. Thromb Haemost 1994; 71: 698-702.
-
(1994)
Thromb Haemost
, vol.71
, pp. 698-702
-
-
Alhenc-Gelas, M.1
Jestin-Le Guernic, C.2
Vitoux, J.F.3
Kher, A.4
Aiach, M.5
Fiessinger, J.N.6
-
50
-
-
0024398566
-
The relationship between antifactor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement
-
Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. The relationship between antifactor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost 1989; 62: 940-44.
-
(1989)
Thromb Haemost
, vol.62
, pp. 940-944
-
-
Levine, M.N.1
Planes, A.2
Hirsh, J.3
Goodyear, M.4
Vochelle, N.5
Gent, M.6
-
51
-
-
0028923828
-
Contemporary laboratory monitoring of low molecular weight heparins
-
Samama MM. Contemporary laboratory monitoring of low molecular weight heparins. Clin Lab Med 1995; 15: 119-23.
-
(1995)
Clin Lab Med
, vol.15
, pp. 119-123
-
-
Samama, M.M.1
-
52
-
-
0031680310
-
-
Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med 1998; 122: 799-807.
-
Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med 1998; 122: 799-807.
-
-
-
-
53
-
-
0027983848
-
Low molecular weight heparin therapy: Is monitoring needed?
-
Boneu B. Low molecular weight heparin therapy: is monitoring needed? Thromb Haemost 1994; 72: 330-34.
-
(1994)
Thromb Haemost
, vol.72
, pp. 330-334
-
-
Boneu, B.1
-
56
-
-
0343920880
-
A meta-analysis of low-dose aspirin for prevention of pregnancy-induced hypertensive disease
-
Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 260-64.
-
(1991)
JAMA
, vol.266
, pp. 260-264
-
-
Imperiale, T.F.1
Petrulis, A.S.2
-
60
-
-
0031721822
-
Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?
-
Arnaout MS, Kazma H, Khalil A, Shasha N, Nasrallah A, Karam K, Alam SE. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? Clin Exp Obstet Gynecol 1998; 25: 101-104.
-
(1998)
Clin Exp Obstet Gynecol
, vol.25
, pp. 101-104
-
-
Arnaout, M.S.1
Kazma, H.2
Khalil, A.3
Shasha, N.4
Nasrallah, A.5
Karam, K.6
Alam, S.E.7
-
61
-
-
0344305703
-
Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin
-
Bauersachs R, Lindhoff-Last E. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin. Arch Intern Med 2003; 163: 2788-789.
-
(2003)
Arch Intern Med
, vol.163
, pp. 2788-2789
-
-
Bauersachs, R.1
Lindhoff-Last, E.2
-
62
-
-
0036844013
-
Successful thrombolysis of St. Jude Medical Aortic Prosthesis with tissue-type plasminogen activator in a pregnant woman: A case report
-
Behrendt P, Schwartzkopff B, Perings S, Gerhardt A, Zotz RB, Stauer AB. Successful thrombolysis of St. Jude Medical Aortic Prosthesis with tissue-type plasminogen activator in a pregnant woman: A case report. Cardiol Rev 2002; 10: 349-53.
-
(2002)
Cardiol Rev
, vol.10
, pp. 349-353
-
-
Behrendt, P.1
Schwartzkopff, B.2
Perings, S.3
Gerhardt, A.4
Zotz, R.B.5
Stauer, A.B.6
-
63
-
-
0034893298
-
Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis
-
Ellison J, Thomson AJ, Walker ID, Greer IA. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. BJOG 2001; 108: 757-59.
-
(2001)
BJOG
, vol.108
, pp. 757-759
-
-
Ellison, J.1
Thomson, A.J.2
Walker, I.D.3
Greer, I.A.4
-
64
-
-
4444350472
-
Embolic myocardial infarction in a pregnant woman with a mechanical heart valve on low molecular weight heparin
-
Lavoie JP, Leduc L, Mercier LA. Embolic myocardial infarction in a pregnant woman with a mechanical heart valve on low molecular weight heparin. Can J Cardiol 2004; 20: 917-19.
-
(2004)
Can J Cardiol
, vol.20
, pp. 917-919
-
-
Lavoie, J.P.1
Leduc, L.2
Mercier, L.A.3
-
65
-
-
0029803041
-
Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement
-
Lee LH, Liauw PCY, Ng AS. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996; 76: 628-30.
-
(1996)
Thromb Haemost
, vol.76
, pp. 628-630
-
-
Lee, L.H.1
Liauw, P.C.Y.2
Ng, A.S.3
-
66
-
-
0033980734
-
Low-molecular weight heparin for prosthetic heart valves: Treatment failure
-
Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular weight heparin for prosthetic heart valves: treatment failure. Ann Thoracic Surg 2000; 69: 264-66.
-
(2000)
Ann Thoracic Surg
, vol.69
, pp. 264-266
-
-
Lev-Ran, O.1
Kramer, A.2
Gurevitch, J.3
Shapira, I.4
Mohr, R.5
-
67
-
-
0036122009
-
Anticoagulation for prosthetic heart valves during pregnancy: Is low-molecular-weight heparin an alternative?
-
Leyh RG, Fischer S, Ruhparwar A, Haverich A. Anticoagulation for prosthetic heart valves during pregnancy: Is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg 2002; 21; 577-79.
-
(2002)
Eur J Cardiothorac Surg
, vol.21
, pp. 577-579
-
-
Leyh, R.G.1
Fischer, S.2
Ruhparwar, A.3
Haverich, A.4
-
68
-
-
3342962721
-
Recurrent thrombosis of a mitral mechanical heart valve prosthesis during puerperium - A case report
-
Lisowska A, Prokop J, Hirnle T, Juszczyk G, Skibińska E, Musial WJ, Klonowska-Dziatkiewicz E, Wrabec K. Recurrent thrombosis of a mitral mechanical heart valve prosthesis during puerperium - A case report. Kardiologia Polska 2004; 61, 49-52.
-
(2004)
Kardiologia Polska
, vol.61
, pp. 49-52
-
-
Lisowska, A.1
Prokop, J.2
Hirnle, T.3
Juszczyk, G.4
Skibińska, E.5
Musial, W.J.6
Klonowska-Dziatkiewicz, E.7
Wrabec, K.8
-
69
-
-
0036739677
-
Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation
-
Mahesh B, Evans S, Bryan AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002; 11: 745-50.
-
(2002)
J Heart Valve Dis
, vol.11
, pp. 745-750
-
-
Mahesh, B.1
Evans, S.2
Bryan, A.J.3
-
70
-
-
1842788521
-
Thrombosis of a prosthetic aortic valve during pregnancy despite therapeutic dosage of Nadroparin
-
Obergfell A, Langenfeld H, Hopp H, Steigerwald U, Grossmann R. Thrombosis of a prosthetic aortic valve during pregnancy despite therapeutic dosage of Nadroparin. Thromb Haemost 2004; 91: 839-40.
-
(2004)
Thromb Haemost
, vol.91
, pp. 839-840
-
-
Obergfell, A.1
Langenfeld, H.2
Hopp, H.3
Steigerwald, U.4
Grossmann, R.5
-
71
-
-
0035045330
-
Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: A case report
-
Oles D, Berryessa R, Campbell K, Bhatti MA. Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report. Perfusion 2001; 16: 159-64.
-
(2001)
Perfusion
, vol.16
, pp. 159-164
-
-
Oles, D.1
Berryessa, R.2
Campbell, K.3
Bhatti, M.A.4
-
72
-
-
0035096332
-
Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular-weight heparin
-
Roberts N, Ross D, Flint S, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular-weight heparin. BJOG 2001; 108: 327-29.
-
(2001)
BJOG
, vol.108
, pp. 327-329
-
-
Roberts, N.1
Ross, D.2
Flint, S.3
Arya, R.4
Blott, M.5
-
73
-
-
18144389763
-
Anticoagulation in patients with mechanical valves during pregnancy
-
Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005; 13: 30-33.
-
(2005)
Asian Cardiovasc Thorac Ann
, vol.13
, pp. 30-33
-
-
Geelani, M.A.1
Singh, S.2
Verma, A.3
Nagesh, A.4
Betigeri, V.5
Nigam, M.6
-
74
-
-
0028801291
-
Guidelines for prevention of thromboembolic events in valvular heart disease: Study group of the working group on valvular heart disease of the European Society of Cardiology
-
Gohlke-Barwolf C, Acar J, Oakley C, Butchart E, Burckhart D, Bodnar E et al. Guidelines for prevention of thromboembolic events in valvular heart disease: study group of the working group on valvular heart disease of the European Society of Cardiology. Eur Heart J 1995; 16: 1320-30.
-
(1995)
Eur Heart J
, vol.16
, pp. 1320-1330
-
-
Gohlke-Barwolf, C.1
Acar, J.2
Oakley, C.3
Butchart, E.4
Burckhart, D.5
Bodnar, E.6
-
75
-
-
33747116680
-
-
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Writing Committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-231.
-
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Writing Committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-231.
-
-
-
-
77
-
-
34250759244
-
-
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M et al. Prevention of infective endocarditis: guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; April: ePublication. 1736-54.
-
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M et al. Prevention of infective endocarditis: guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; April: ePublication. 1736-54.
-
-
-
|